EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison

Juan Antonio K Chong Chie iD, Scott A Persohn, Olivia R Simcox, Alyssa Collins, Paul Salama, Paul R Territo iD, Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium

Alzheimer's & Dementia · 2026-05 · 22 (5)

DOI: 10.1002/alz.71496 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 18.05.2026. Verfasst von Juan Antonio K Chong Chie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Connectome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Stark Neuroscience Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Historically, imaging diagnostics in Alzheimer's disease (AD) have focused primarily on amyloid and tau accumulation; however, recent work suggests that neurometabolic and vascular dysregulation (MVD) may precede protein deposition and persist throughout the disease spectrum, preclinically and clinically. Translating these findings between human patients and preclinical mouse models remains challenging due to cross‐species differences. To address this, regional MVD phenotypes were identified using cerebral metabolism and blood flow, and region‐set enrichment analysis (RSEA) was conducted to assess brain functional category (BFC) changes based on metabolic variations, facilitating systematic cross‐species comparisons. Clinically, MVD showed progressive alterations across the AD spectrum, while mouse models demonstrated similar genotype‐ and age‐dependent changes. Although direct one‐to‐one regional correspondence is limited, RSEA revealed changes in comparable BFCs. Our findings suggest that imaging‐based MVD mapping and RSEAs can bridge species differences, offering a translational framework to support early diagnostics of AD, enhance disease stratification, and enable therapeutic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBrainConnectomeAnimalsHumansDisease Models, AnimalMiceFemaleMaleMagnetic Resonance ImagingCerebrovascular CirculationPositron-Emission TomographyAgedMice, TransgenicAged, 80 and over

Stichwörter der Autor:innen

biomarkersbrain reorganizationclinicalconnectomicsdysregulationmetabolismperfusionperspectivepreclinicaltranslationaluncoupling

Autor:innen und Institutionen

  • Stark Neuroscience Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Wood College of Osteopathic Medicine, Marian University, Indianapolis, Indiana, USA.
  • School of Electrical and Computer Engineering, Purdue University, Indianapolis, Indiana, USA.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID-Profile: Juan Antonio K Chong Chie, Paul R Territo

Förderung

  • NIA NIH HHS
  • Stark Neuroscience Research Institute

Zitieren

APA

Chong Chie, J. A. K., Persohn, S. A., Simcox, O. R., Collins, A., Salama, P., Territo, P. R., & Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium (2026). Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison. Alzheimer's & Dementia, 22(5). https://doi.org/10.1002/alz.71496

Vancouver

Chong Chie JAK, Persohn SA, Simcox OR, Collins A, Salama P, Territo PR, et al. Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison. Alzheimer's & Dementia. 2026;22(5). doi:10.1002/alz.71496

BibTeX
@article{ChongChie2026,
  author = {Chong Chie, Juan Antonio K and Persohn, Scott A and Simcox, Olivia R and Collins, Alyssa and Salama, Paul and Territo, Paul R and Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium, Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium},
  title = {Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {5},
  doi = {10.1002/alz.71496}
}
Kostenlos starten →